Aller au contenu principal
Profil bibliographique

Haifeng Lan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

15Publications signalées
36Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Colorectal Cancer Screening and DetectionGastric Cancer Management and OutcomesCAR-T cell therapy researchLymphoma Diagnosis and TreatmentAcute Myeloid Leukemia Research

Les publications récentes

Accès ouvert 2022 preprint OpenAlex

Identification of GLP1R and MCHR1 signaling as novel GPCR targets of MRAP2 protein

Meng Wang, Xu Jing, Xiaowei Lei, Cong Zhang et autres

The seven trans-membrane spanning G protein couple receptors(GPCRs) constitute the largest family of FDA approved drug targets to treat numerous human diseases, including metabolic associated disorders. The Melanocortin Receptor Accessory Protein 2 (MRAP2), a small single transmembrane protein broadly expressed in multiple …

cn (code pays fourni par la source)

0 citations
2020 conference-abstract OpenAlex

Abstract LB-379: Dominant negative PD1 armored CAR-T cells induce remission in relapsed or refractory non-Hodgkin lymphoma (NHL) patients

Yan Yuan, Liansheng Huang, Su Yang, Chengfei Pu et autres

Abstract The chimeric antigen receptor (CAR) T cell treatment has been demonstrated as an effective therapy to treat relapsed/refractory B cell malignancy. However, tumor microenvironment influences and affects the efficacy of CAR T treatment. For example, programmed death ligand 1/2 (PDL1/2) may …

cn, gb (code pays fourni par la source)

0 citations Cancer Research
Accès ouvert 2020 article OpenAlex

High Expression of the SH3TC2-DT/SH3TC2 Gene Pair Associated With FLT3 Mutation and Poor Survival in Acute Myeloid Leukemia: An Integrated TCGA Analysis

Pengfei Yu, Haifeng Lan, Xianmin Song, Zengkai Pan

Fms-like tyrosine kinase 3 (FLT3) mutation is one of the most common mutations in acute myeloid leukemia (AML). However, the effect of FLT3 mutation on survival is currently still controversial and the leukemogenic mechanisms are still under further investigation. The aim of …

de, cn (code pays fourni par la source)

17 citations Frontiers in Oncology
2020 conference-abstract OpenAlex

Dominant negative PD1 armored CART cells to induce remission in relapsed or refractory non-Hodgkin lymphoma (NHL) patients.

Chengfei Pu, Liansheng Huang, Yang Su, Tianling Ding et autres

e15028 Background: The chimeric antigen receptor (CAR) T cell treatment has been demonstrated as an effective therapy to treat relapsed/refractory B cell malignancy. However, tumor microenvironment influences and affects the efficacy of CAR T treatment. For example, programmed death ligand 1/2 (PDL1/2) …

cn (code pays fourni par la source)

2 citations Journal of Clinical Oncology
2013 other OpenAlex

[The efficacy and safety analysis of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma].

Jing Lü, Jian Hou, Chunyang Zhang, Zhen-Gang Yuan et autres

OBJECTIVE: To evaluate the efficacy and safety of bortezomib retreatment in 76 patients with relapsed/refractory multiple myeloma (MM), who previously responded to bortezomib. METHODS: Retrospective analysis of 76 MM patients, who had achieved at least a partial response (PR) on initial bortezomib …

cn (code pays fourni par la source)

3 citations PubMed
2012 other OpenAlex

[Clinical observation of prophylactic lactulose for prevention of oral morphine-induced constipation].

Zhan Wang, Jianxin Qian, Xiao‐Dong Jiao, Lingyan Yuan et autres

OBJECTIVE: To evaluate the effects of different doses of lactulose on preventing oral morphine-induced constipation. METHODS: From January 2011 to May 2012, a total of 112 patients received oral lactulose solution to prevent morphine-induced constipation at our hospital and their clinical data …

cn (code pays fourni par la source)

2 citations PubMed
2012 other OpenAlex

[Allogeneic peripheral blood stem cell transplantation from sibling donors for 10 patients with multiple myeloma].

Haifeng Lan, Zhengang Yuan, Chunyang Zhang, Yubao Chen et autres

OBJECTIVE: To evaluate the efficacy of allogeneic peripheral blood stem cell transplantation (allo-PBSCT) from sibling donors for treatment of multiple myeloma (MM). METHODS: Ten patients with MM received allo-PBSCT with conditioning consisting of fludarabine plus melphalan and cyclophosphamide mostly.CsA plus mycophenolate mofetil …

cn (code pays fourni par la source)

1 citation PubMed

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.